Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled A

循环维生素 D 水平与乳腺癌和结直肠癌的风险：汇总 A

• 批准号: 8115235
• 负责人: STEPHANIE A SMITH-WARNER
• 金额: $ 45.71万
• 依托单位: HARVARD SCHOOL OF PUBLIC HEALTH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8115235
• 关键词: 25-hydroxyvitamin D; Asia; Biochemical; Biological Markers; Blood specimen; Cancer Burden; Characteristics; Cohort Studies; Collaborations; Colorectal Cancer; Confounding Factors (Epidemiology); Data; Databases; Dose; Epidemiology; Estrogen Receptors; Estrogen receptor positive; Etiology; Europe; Future; Genetic Polymorphism; Genetic Variation; Health; Health Status; Heterogeneity; Incidence; Individual; Insulin-Like Growth Factor I; Intake; Literature; Malignant Neoplasms; Measurement; Measures; Meta-Analysis; Modeling; North America; Personal Communication; Population; Positioning Attribute; Principal Investigator; Progesterone Receptors; Prospective Studies; Publication Bias; Publications; Publishing; Recommendation; Rectal Cancer; Reporting; Research Design; Research Personnel; Risk; Risk Factors; Skin Cancer; Source; Subgroup; Sun Exposure; Tumor Subtype; United States; Vitamin D; Vitamin D3 Receptor; Woman; base; calcium intake; cancer risk; cancer site; cohort; design; diet and cancer; experience; inclusion criteria; insight; lifestyle factors; malignant breast neoplasm; melanoma; men; older women; programs; prospective; public health relevance; randomized trial; response; tumor

DESCRIPTION (provided by applicant): We propose to conduct a prospective, pooled analysis of the association between circulating 25- hydroxyvitamin D [25(OH)D] levels and risk of breast and colorectal cancer within a consortium of 15 cohort studies. We hypothesize that higher levels of circulating 25(OH)D levels are associated with a reduced risk of colorectal and breast cancer. These associations are hypothesized to be stronger among leaner individuals, among more physically active individuals, and among individuals with higher calcium intakes. Inclusion criteria for participation in the consortium are that a study used a prospective study design, collected blood samples prospectively, and had at least 50 cases of the specific cancer being analyzed. The 15 studies in the consortium were conducted in North America (n=10), Europe (n=4), and Asia (n=1) and include 5061 colorectal cancer cases and 6817 breast cancer cases whose circulating 25(OH)D levels have been measured previously or will be measured (mostly as part of this proposal). We will analyze the primary data from each study so that circulating 25(OH)D levels and confounding variables will be modeled consistently across studies. This will reduce potential sources of between-studies heterogeneity due to different analytic approaches as encountered in the published literature, as well as allow for examination of different categorizations of circulating 25(OH)D levels. We also will be able to evaluate whether associations vary among population subgroups, by other biochemical risk factors, and by tumor subtypes which cannot be evaluated fully in a meta-analysis of the published literature. Further, new data will be generated in seven of the studies which will reduce the influence of publication bias. This proposal takes full advantage of extensive data collected throughout the world, builds upon the expertise and established collaboration of the investigators, and takes advantage of the statistical power of the project. These analyses will provide powerful insights into the relation between vitamin D and breast and colorectal cancer risk. The results have the potential to inform recommendations regarding sun exposure and vitamin D intake requirements, and contribute to the reduction of the burden of cancer. PUBLIC HEALTH RELEVANCE: Confirming whether vitamin D reduces the risk of breast and colorectal cancer, two of the most common cancers in the United States, is critical because current health recommendations typically do not encourage intakes of vitamin D high enough to appreciably influence 25(OH)D levels and they tend to discourage sun exposure because of the risk of skin cancer and melanoma.

描述（由申请人提供）：我们建议在15项队列研究中对循环25-羟基维生素D [25（OH）D]水平与乳腺癌和结直肠癌风险之间的关联进行前瞻性汇总分析。我们推测，较高水平的循环25（OH）D水平与结直肠癌和乳腺癌的风险降低有关。假设这些关联在较瘦的个体中，在身体活动较多的个体中，以及在钙摄入量较高的个体中更强。参与该联盟的入选标准是，研究采用前瞻性研究设计，前瞻性收集血液样本，并分析至少50例特定癌症病例。该联盟的15项研究在北美（n = 10）、欧洲（n = 4）和亚洲（n = 1）进行，包括5061例结直肠癌病例和6817例乳腺癌病例，这些病例的循环25（OH）D水平先前已被测量或将被测量（主要作为本提案的一部分）。我们将分析每项研究的主要数据，以便在研究中对循环25（OH）D水平和混杂变量进行一致的建模。这将减少因已发表文献中遇到的不同分析方法导致的研究间异质性的潜在来源，并允许检查循环25（OH）D水平的不同分类。我们还将能够评估不同人群亚组、其他生化风险因素和肿瘤亚型之间的相关性是否存在差异，这些因素在已发表文献的荟萃分析中无法充分评估。此外，7项研究将产生新的数据，这将减少发表偏倚的影响。这项建议充分利用了在世界各地收集的大量数据，利用了调查人员的专门知识和已建立的协作，并利用了该项目的统计能力。这些分析将为维生素D与乳腺癌和结直肠癌风险之间的关系提供强有力的见解。这些结果有可能为有关阳光照射和维生素D摄入量要求的建议提供信息，并有助于减少癌症负担。 公共卫生相关性：明确维生素D是否能降低乳腺癌和结直肠癌的风险，这是美国最常见的两种癌症，这一点至关重要，因为目前的健康建议通常不鼓励摄入足够高的维生素D，以明显影响25（OH）D水平，而且由于皮肤癌和黑色素瘤的风险，他们往往不鼓励阳光照射。